InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
3
Disclosed sells
0
T+90 hit rate
33%
T+90 mean return
-0.8%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Chardonnet Laurent, Chief Financial Officer. Officer active across 1 company, notably Prelude Therapeutics Inc. Cumulatively, 5 reports have been logged. Split: 3 buys · 0 sell. Total volume traded: €111k. History available since 13 December 2021. The latest transaction was filed on 23 May 2023 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Chardonnet Laurent
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
5,000 shares@ US$5.509.7% of flowCommon StockSEC:0001562180-23-004477:0
Canonical exit: 21 Aug 2023 (T+90)
10,000 shares@ US$4.7617.2% of flowCommon StockSEC:0001562180-22-008192:0
Canonical exit: 8 Mar 2023 (T+90)
10,000 shares@ US$4.230.011% mcap20.6% of flowCommon StockSEC:0001562180-22-004627:0
Canonical exit: 30 Aug 2022 (T+90)
6,500 shares@ US$7.510.012% mcap23.0% of flowCommon StockSEC:0001209191-22-020585:0
5,000 shares@ US$12.280.015% mcap28.2% of flowCommon StockSEC:0001209191-21-069548:0
5 of 5 declarations
About Chardonnet Laurent
Laurent Chardonnet is the Chief Financial Officer at Prelude Therapeutics Inc. He is responsible for financial management and strategy of the company. His role is crucial in ensuring financial health and growth.
